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Removal of long-cham asparaglne-IInked carbohydraies leads to loss of r~eptor-effe~tor coupling m go- 
nadotropin target tissue This Implies a direct mterachon between carbohydrate and ceil membrane compo- 
nents To examme other mechanisms by which carbohydrate could activate post-receptor events, we have 
used sequence-specdic and conformation-speatic a-subunit radlolmmunoassays as probes for conforma- 
tlonal changes m deglycosylated chorlogonadotropm and folhtropm Immunoreactlvlty of either hormone 
was enhanced 8-13-fold after removal of carbohydrate by anhydrous hydrogen fluoride Removal of slahc 
acid alone had little effect on reactlvlty Based on the speclficlty of the an&era, the effect could be locahzed 
to a region rn the ammo-termmus remote m the linear sequence from actual sites of carbohydrate attach- 
ment The results suggest that a conformatlonal change m the cr-subumt could account, at least m part, 
for the observed effects of deglycosylatlon on glycoprotem hormone action 
Carbohydrate Glycoprotem Folhtropm Chorzogonadotropm Conformation Membrane receptor 
1. INTRODUCTION 
There IS now extensrve evidence that car- 
bohydrate srde-chains are essential for the target- 
organ actions of the several glycoprotein hor- 
mones: lutropm (LH), folhtropm (FSH), 
chorrogonadotropm (hCG) and thyrotropin 
(TSH). Several aboratorres have shown that recep- 
tor bmdmg 1s unchanged or even enhanced, while 
post-receptor events such as adenylate cyclase ac- 
tivation or steroid production are markedly 
drmmished after deglycosylatron of the hormone 
by enzymatic or chemical means [l-6]. 
The mechanism by which these side-chams exert 
their effects on biologtcal activity have not yet 
been established. Although the results to date 
pomt to a drrect role for carbohydrate m recep- 
tor/cyclase ‘coupling’, rt IS also possrble that subtle 
conformatronal changes in the peptrde chain might 
account, at least m part, for the observed effects of 
carbohydrate removal. 
We have used immunoassays based on regron- 
specific antisera to tu-subumt o provide evrdence 
that a conformatlon~ change does in fact occur 
consequent to chemical deglycosylatron of both 
hCG and human folhtropm 
2 MATERIALS AND METHODS 
hCG was purchased m partially purrfred form 
from Organon Ltd (Oss, The Netherlands) and 
purified by gel filtration and ion-exchange 
chromatography [6,7]. cu-Subumt was separated by 
urea/DEAE chromatography and gel filtration [7], 
Purified human FSH (hFSH; preparation 
AFP-4161B) was obtained from the Natronal Hor- 
mone and Prtmtary Program (Baltimore, MD). 
Reduced, carbox~ethylated (RCXM) hormones 
and subunits were prepared by treatment wrth 
dtthrothrertob’guamdme hydrochlorrde followed 
by rodoacetic acid as descrrbed [6]. 
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2.1. Deglycosylatlon 
Ahquots (2-5 mg) of whole hCG, cu-subumt, or 
hFSH were treated with anhydrous HF without 
scavenger for 1 h at 0°C m a Kel-F dlsttllatron ap- 
paratus (Protein Research Foundation, Osaka, 
Japan) [3,6]. Modified hCG and hFSH were 
separated from cleaved carbohydrate by gel ftltra- 
tion on Sephadex G-100 (Pharmacra, Prscataway, 
NJ) eluted with 0.2 M ammonium bicarbonate 
buffer, pH 8 7 [6]. a-Subunit was separated using 
Sephadex G-25 with 0.1 M acettc acid. 
Desralylated hCG and cu-subunit were prepared by 
treatment with neurammrdase (Worthmgton, 
Freehold, NJ) at pH 5.0 for 1 h at 37°C [7]. 
2.2 Radiolmmunoassays 
Assays for native hCG and its subunits and for 
hFSH were carried out by a double-antibody 
technique described by Farman and Ryan [S], using 
radrotodmated native hormone as tracer. The 
respective antisera employed are detailed m table 
1. Sequence-specific rmmunoassays from RCXM 
a-subunit were done as described by Keutmann et 
al. [9], using 3 amino-terminal-directed antisera: 
nos 101, 110 and 118 RCXM-LY was used as an- 
tigen, labeled tracer and reference standard The 
conformation of the cu-subunit was also probed us- 
mg a monoclonal antibody (no.AlOl), raised 
against native hFSH and reacting predommantly 
with the cu-subunit m associated native hFSH 
(HOJO, H. and Ryan, R.J., m preparation). Details 
of the assay are given m section 3 and the legend 
to fig.4. 
The true peptrde weight of each hormone 
preparation was fixed by ammo acid analysis, and 
relative potencies of deglycosylated vs native hor- 
mone or subunit were computed from the response 
curves as m [6] 
3 RESULTS 
3.1. Chemrcal propertles of deglycosylated 
hormones 
Consistent with our earlier findings, HF treat- 
ment removed 80% of long-chain, asparagme- 
linked carbohydrate from hCG, hFSH and cy- 
subunit. Remaining carbohydrate was predomt- 
nantly N-acetylglucosamme adjacent to asparagme 
residues (normally resistant to cleavage by HF), 
and 6-12070 of mannose residues from the ‘core’ 
334 
region of the chain. Detailed chemical analysts [6] 
showed the peptrde chain to be intact after HF 
treatment 
3 2 Assays of hCG wrth sequence-specrflc 
an trsera 
Immunoreacttvtty of hCG with antrsera to 
native hormone or cu-subunit was reduced by 
30-60% after deglycosylatron [6] (table la). By 
contrast, when tested m assays for RCXM-a- 
subunit, reactivity of whole hCG and hCG_(y was 
markedly enhanced after deglycosylatron (fig. 1). 
Drsplacement curves for Lu-subunit were parallel, 
and the relative potencres of deglycosylated cy- 
subunit were 8-13-fold higher than unmodified 
subunit (table 1 b). Reactivity of unmodified whole 
hCG was typically weak, but assumed a slope 
parallel to a and RCXM_(y wtth a similar increased 
Table 1 
Immunoreactivrty of deglycosylated hCG and 
cu-subunrts 
Hormone Antrserum Relatrve potency 
(a) Assays with name antisera 
(Degly) hCG hCG R2000 0 41 
(Degly) hCG hCG R2005 0 60 
(Degly) hCG hCG-a SA-6 0 69 
(Degly) hCG hCG+’ Rl-10 0 87 
(b) Assays with RCXM-a antlsera 
(deglycosylated hormones) 
(Degly) hCG 101 
(Degly) hCG 110 
(Degly) a 101 
(Degly) cy 110 
(Degly) cy 118 
(Degly) RCXM-a 101 
(Degly) RCXM-a 110 
13 1 
80 
78 
10 8 
13.3 
1 25 
1 07 
(c) Assays with RCXM+ antlsera 
(deslalylated hormones) 
(Aslalo) hCG 101 1 40 
(Aslalo) hCG 110 1 00 
(Aslalo) hCG 118 1 13 
(Aslalo) a 101 1 71 
(Aslalo) a 110 1 49 
(Aslalo) CY 118 I 40 
Relative potency = activity ratlo (treated hCG)/ 
(untreated hCG) or (treated cu)/(untreated (Y) 
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Fig 1. Displacement curves for hCG and cu-subumt 
preparations m a radlolmmunoassay with sequence- 
specific antibody (no 110). Abscissa shows peptlde 
weight (ng) by ammo acid analyas, and ordinate shows 
proportion of total bound ‘251-labeled RCXM-CY tracer 
displaced by mcreasmg doses of hormone. Immuno- 
potency of both whole hCG and a+subumt were 
enhanced after deglycosylatlon, while no change was 
detected after deglycosylatron f RCXM-a! antigen. 
potency after deglycosylation (fig.1). It should be 
noted that even after degly~osylation, the reac- 
tivities of the fully folded natrve hormones were 
about IOO-fold less than the hneartzed RCXM-ar 
antigen. 
from hCG or a-subunit effected a slight increase in 
lmmunoreactivity with the RCXM-c~ antisera, 
ranging from equivalent o 1.7-fold depending on 
the antiserum employed (fig.2, table lc). 
3.3. Assays of hFSH wzth name and sequence- 
specrftc antisera 
RCXM-cu-subunit itself was tested before and Reactivity of deglycosylated hFSH was reduced 
after deglycosylatron. The untreated pepttde was, to 42Vo of untreated hormone when tested with 
as expected, similar m reactivity to our purrfred native hFSH polyclonal antiserum 12456 (fig.3a). 
RCXM-cv standard, and no stgmfrcant change m Results of assays with RCXM-c~ antisera were 
reactivity was observed following deglycosylation comparable to those obtained with hCG; reactivity 
(fig.1, table lb). Removal of termmal sralic acid with As no.110 was enhanced ‘f-fold after 
Fig 2. Dose-response curves for deslalylated (As) and 
native hCG preparations m sequence-specific radio- 
immunoassay usmg antlbody no 110 Increase m 
reactivity was mInima compared to more completely 
deglycosylated preparations (fig. 1) Coordmates are 
labeled as m fig.1 
o----_o, 
‘\ 
‘7 
‘. 
dg FSH ‘” 
\ 
Rg 3. (A) Displacement curves for native human FSH m assay using polyclonal an&hFSH antibody 12456, showing 
decrease m reactlvlty of hFSH after deglycosylatlon (B) Same preparations m sequence-speclfrc assay using antibody 
no. 110, showmg increase m reactlvlty of deglycosylated hFSH 
335 
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Table 2 
Immunoreactivity of deglycosylated hFSH and 
cy-subunits 
Hormone Antiserum Relative potency 
(a) Assay with polyclonal native antiserum 
(Degly) hFSH hFSH 12456 0.42 
(b) Assays with RCXM-r~ antisera 
(Degly) hFSH 101 
(Degly) hFSH 110 
(Degly) hFSH 118 
12 0 
70 
90 
(c) Assays with monoclonal antibody to LY subunit 
of native hFSH 
(Degly) hFSH Al01 0 019 
Native (Y Al01 0.003 
(De&) LY Al01 0 02.5” 
RCXM cy Al01 <o 0007 
a Potency (degly cu)/(native cu) = 7 5 
Relative potency = activity ratio (degly hFSH or cy- 
subunit)/(natlve hFSH) 
deglycosylatron (fig.3b) and similar mcreases were 
observed with As nos 101 and 118 (table 2b). 
3.4. Assays with a conformatlonally dependent 
monoclonal antibody 
Monoclonal anttbody no Al01 recognized cy- 
subumt m a manner highly specific for associated 
“g/Tube 
Fig 4 Dose-response curves for native and 
deglycosylated hFSH and cY-subumt usmg a 
conformatlonally dependent monoclonal antibody 
Incubation mixtures contamed 2 ng 1251-labeled hFSH 
and 9 ng monoclonal antlbody A no 101, Incubated m 
1 ml of 40 mM Trls-HCl, pH 7 4, for 24 h at 20°C and 
separated by the double antlbody techmque [8] 
Absolute (speafic) bmdmg was 30% Relative potencies 
are summarized m table 2c 
hFSH; whole hFSH reacted 300-trmes greater than 
free cu-subumt and 34-times greater than hCG 
(HOJO, H. and Ryan, R.J , m preparation). Reac- 
tivity with hFSH was markedly dtmmlshed after 
deglycosylation, to a potency only 2% of untreated 
hormone (fig.4; table 2c) Deglycosylated a- 
subunit was Increased m reactivity by 7.5fold over 
untreated cy. Deglycosylated hCG was shghtly 
(1.36-fold) increased m potency over nattve hCG. 
4. DISCUSSION 
The asparagme-linked long-chain carbohydrate 
on both subunits is clearly essential for coupling of 
receptor to post-receptor events m gonadotropm 
target tissues. The requirement for carbohydrate 
appears to occur at an early stage after receptor 
bmdmg, since both the nucleotide-bmdmg protem 
and adenylate cyclase enzyme in ovarian cells re- 
mam responsive to guanme nucleotides m the 
presence of deglycosylated hCG [lo]. 
These observatrons imply a drrect mvolvement 
of carbohydrate, either by mfluencmg the confor- 
mation of the hormone-receptor complex or 
through mteraction with a carbohydrate-bmdmg 
moiety or lectm m the cell membrane. We have 
been unable to restore adenylate cyclase activity by 
simply adding back the cleaved carbohydrate frac- 
tion after deglycosylatron. However, Calvo and 
Ryan [l l] have shown that glycopeptides contam- 
ing intact carbohydrate can inhibit activation of 
ovarian adenylate cyclase by native hCG. The ef- 
fect IS specific, since no inhibition was observed 
with glycopeptrdes or ohgosaccharides from other 
sources. Carbohydrate bindmg to a membrane lec- 
tin component could, for example, promote recep- 
tor crosslmkmg as an uutial step m cyclase activa- 
tion [lO,ll]. 
As an alternatrve explanation, a conformational 
change affecting one or both subunits is important 
to consider, since both antigemc and receptor 
bmdmg sites m the glycoprotem hormone molecule 
appear to be highly dependent on 3-dimensional 
structure. Direct measurements by crrcular 
drchrorsm (CD) [3,5,6] or ANS fluorescence [3] 
have not revealed malor conformational changes 
m hCG after deglycosylation. Evidence for m- 
creased heat stability [12] and an enhanced rate of 
LH subunit reassociation as measured by tyrosme 
spectrum [ 131 suggested some alteration m confor- 
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matlon. Although maJor conformational changes 
were not apparent by CD measurements of 
deglycosylated hCG [6], we have found differences 
in the CD spectrum between deglycosylated and in- 
tact hFSH (Charlesworth, C., Ryan, R.J. and 
Keutmann, H T , unpublished). Our additional 
evidence for a conformational change, based on a 
small but consistent decrease m lmmunoreactlvlty 
of hCG with native polyclonal antisera after 
deglycosylatlon, prompted us to examme the HF- 
treated preparations with region-specific and con- 
formationally dependent antibodies 
Antlsera prepared against RCXM a-subunit 
generally have reacted only weakly with native hor- 
mone [9,14,15]. Our current results show that, 
while still substantially lower than RCXM-+- 
subunit itself, the reactivity of both a-subunit and 
whole hormone after deglycosylatlon 1s strlkmgly 
increased over that of the untreated native pep- 
tides. The findings suggest a change towards a 
more ‘linear’ conformation m the sequence region 
recognized by the antiserum. 
Studies with the conformatlonally dependent 
monoclonal antibody A no.101 also indicated a 
change in the conformation of hFSH+. This an- 
tibody recognizes the cu-subunit of hFSH better 
than the cu-subunit in hCG and free cY-subunit (see 
section 3). Deglycosylation strlkmgly dlmmlshed 
reactlvlty with the associated FSH a-subunit to on- 
ly 2% of the untreated hormone, while recogmtlon 
of the free subunit was enhanced. These effects ap- 
pear specific for FSH because reactivity with hCG 
was not markedly altered after deglycosylatlon. 
The results also extend to deglycosylated subunit 
observations made previously that the conforma- 
tion of the cr-subunit 1s influenced by the presence 
and type of P-subunit [16]. 
We were able to rule out several other potential 
causes of enhanced immunoreactlvity. Clips m the 
peptlde chain as a result of HF treatment might 
produce reactive linear segments or altered confor- 
mation despite intact dlsulflde bridges However, 
we have shown by detailed chemical and sequence 
analyses [6] of these and other preparations that 
the peptlde chain remains intact and undamaged 
after the deglycosylatlon procedure. Neuramm- 
ldase-treated hCG preparations were assayed since 
there IS evidence that slahc acid alone can influence 
reactivity of hCG with anti-native antisera [ 17,181. 
We found deslalylatlon to enhance reactivity only 
shghtly, if at all, with our RCXM-(Y antisera. 
Furthermore, smce lmmunoreactlvlty of the 
RCXM-a antigen itself was unchanged after HF 
treatment, direct mvolvement of carbohydrates m 
antibody recognition was not a factor. Local 
changes close by the sites of carbohydrate attach- 
ment also are unlikely m view of a recent report 
[19] that the conformation of adJacent ammo acids 
1s not affected by glycosylation. 
The 3 RCXM-a antisera used here were directed 
toward a segment close to the ammo-terminus of 
the a-subunit [9]. This region IS remote m the 
linear sequence from the sites of carbohydrate at- 
tachment at posltlons 52 and 78, although in the 
folded native subunit it may be looped mto a posl- 
tlon vlcmal to one or both carbohydrates. The 
recognition site includes an aromatic residue (Phe) 
at position 17, shown by structure-function studies 
with ovine and porcine LH to be ‘exposed’ and 
perhaps accessible to the cell surface in the native 
hormone [20-221. The cystme disulfide bridge be- 
tween residues 11 and 35 m bovine LH-cy (cor- 
responding to cysteines 7-31 m hCG-cY) has been 
selectively reduced and carbammomethylated and 
the modified subunit reassociated with P-subunit 
[22]. The recombinant bound to receptors and the 
CD spectrum was not changed despite loss of the 
disulflde linkage. This offers a precedent for a 
molecule with altered conformation m the N- 
terminal region of cu-subunit showing subumt- 
assoclatlon, receptor-bmdmg and CD properties 
similar to those found m the deglycosylated 
hormone. 
The concept of a conformatlonal change IS sup- 
ported by the results of Rebels and Flshman [23] 
who restored adenylate cyclase activity to Leydlg 
cell incubates of deglycosylated hCG by addition 
of anti-hCG antisera Since antisera to cu-subunit 
did not restore activity, the sequence region m- 
volved may be different from that identified m our 
studies. Although their fmdmgs suggest that the 
deglycosylated molecule can be reformed readily to 
an active conformation, the polyvalent antibody 
might also be activating adenylate cyclase by 
crosshnkmg or redistributing the hCG-receptor 
complexes [ 10,11,24]. 
Antisera to other regions of hCG and LH are m 
preparation for use as probes for conformatlonal 
changes elsewhere m the molecule. While our 
present results are consistent with an influence of 
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carbohydrate on the conformatton of the a- 
subunit, it remains to be determmed whether the 
effects of deglycosylatton can be attributed to thts 
factor alone, to altered mteractton between car- 
bohydrate and membrane components, or both. 
Ultimately, since deglycosylatton affects both 
receptor bmdmg (enhanced) and cyclase actrvatron 
(dtmmtshed), each mechanism may prove responst- 
ble for actions at separate stages of the target cell 
response. 
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